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Abstract
Background: Sexually transmitted infections (STI) care in the Netherlands is primarily provided by general practitioners 
(GPs) and specialized STI centers. STI surveillance is based on data from STI centers, which show increasing numbers of 
clients. Data from a GP morbidity surveillance network were used to investigate the distribution in the provision of STI 
care and the usefulness of GP data in surveillance.
Methods: Data on STI-related episodes and STI diagnoses based on ICPC codes and, for chlamydia, prescriptions, were 
obtained from GP electronic medical records (EMRs) of the GP network and compared to data from STI centers from 
2002 to 2007. Incidence rates were estimated for the total population in the Netherlands.
Results: The incidence of STI-consultations and -diagnoses increased substantially in recent years, both at GPs and STI 
centers. The increase in consultations was larger than the increase in diagnoses; Chlamydia incidence rose especially at 
STI centers. GPs were responsible for 70% of STI-related episodes and 80-85% of STI diagnoses. STI centers attract 
relatively younger and more often male STI-patients than GPs. Symptomatic STIs like Herpes genitalis and genital warts 
were more frequently diagnosed at GPs and chlamydia, gonorrhea and syphilis at STI centers.
Conclusions: GPs fulfill an important role in STI care, complementary to STI centers. Case definitions of STI could be 
improved, particularly by including laboratory results in EMRs. The contribution of primary care is often overlooked in 
STI health care. Including estimates from GP EMRs can improve the surveillance of STIs.
Background
In the Netherlands, healthcare for people with sexually
transmitted infections (STIs) is provided by general prac-
titioners (GPs), specific STI centers, HIV treatment cen-
ters and specialized hospital care [1]. Patients will be
referred from GPs or STI centers to receive more special-
ized care in HIV treatment centers or hospitals. In gen-
eral, GPs act as 'gatekeeper', the primary point of access
to healthcare [2]. The Netherlands accommodates over
4,300 general practices with about 8,700 practitioners and
every Dutch inhabitant is connected to a general practice
[3]. Costs of GP consultation, STI-tests and treatment are
covered by the national -since 2006- statutory, health
insurance [4]. STI care through specialized STI centers is
an additional first line service, providing free, anony-
mous, low-threshold STI care to higher risk groups, fit-
ting certain criteria (a.o. age, sexual preference, recent
risk), who might not visit a GP for these specific prob-
lems. The STI centers receive government funding; the
number of consultations in these facilities continuously
increased in the past decade [5].
Reportedly, the majority of patients with STI-related
problems are seen in primary care. In 2001, a survey in 75
practices estimated that countrywide 98,000 episodes at
GPs were related to STI/HIV care [6], while STI centers
reported 38,000 clients. In population surveys about sex-
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ual healthseeking behavior, the majority of persons with
STI-related complaints or in want of an STI-test con-
sulted a GP and of the remaining most went to an STI
centre [7,8]. Of young people (under 25 years), also nearly
three quarters said they would visit a GP if suspecting an
STI [9]. Other health providers (i.e. hospital policlinics,
centers for sexual health) have a limited role in STI care
in the country. A minority of people looked for testing
and treatment options via the internet. In other coun-
tries, such as Germany and the UK [10-12], specialized
STI-clinics or other care facilities often play a more
important role than GPs in STI-care.
In the Netherlands no complete case-registration exists
for STIs, except for hepatitis B which is a notifiable dis-
ease. National surveillance of STI/HIV now focuses on
STI centers and HIV-treatment centers [5]. thus obtain-
ing detailed data from (presumably) high-risk popula-
tions. Although this surveillance is excellent to monitor
trends and (re-) emergence of STIs, it obviously lacks data
from the general population. With increasing numbers of
clients in STI centers but limited insight in STI trends in
general practices, the question arises whether this STI-
service is starting to replace primary care.
General practitioners in the Netherlands, together with
Sweden and Denmark, were ahead of other countries in
using computers in their daily practice: 88% used elec-
tronic medical recording systems in 2001 [13]. Recently a
new strategy for processing, analyzing and interpreting
EMRs was developed within a national GP network [14]
and estimates of yearly incidence rates became available
for a range of health problems [15] defined by Interna-
tional Classification of Primary Care (ICPC) codes [16].
Here, we investigated the usefulness of EMRs from this
national GP information network to fill the gap in STI
surveillance in the Netherlands. Furthermore, we com-
pared recent STI-trends and population characteristics of
patients seen by GPs and STI centers, to evaluate whether
these two complement each other in the provision of STI
care.
Methods
Data on STI diagnoses were obtained from the GPs EMR
database of the Netherlands 'Information Network of
General Practice' (LINH) and the national STI surveil-
lance database of STI centers from the National Institute
of Public Health (SOAP) from 2002 to 2007.
General Practioners
Data collection
Anonymous GP data were obtained from the Nether-
lands Information Network of General Practice (LINH)
after approval by the LINH steering committee. LINH
started in 1992 and developed into a system recording
longitudinal data on morbidity, prescriptions and refer-
rals from patients subscribed in participating practices.
The pool of practices fluctuates from year to year, but its
composition is guarded to provide a representative sam-
ple of about 2% of the Dutch population regarding age
and gender in comparison with Dutch National Statistics
[17] and the practices are representative of all Dutch gen-
eral practices with respect to geographical distribution
and degree of urbanization [14,18,19]. For estimating
morbidity rates, EMRs of individual GP-patient-contacts
are grouped into episodes of care (concerning one health
problem), as registered directly by the GPs (when avail-
able) or by constructing episodes with the validated appli-
cation EPICON [20], grouping contacts with similar
ICPC-codes less than two months apart. Individual
patients' characteristics include age, sex, urban/rural resi-
dence (address density) and living in deprived areas
(defined by GP-capitation fee).
Definition of STI diagnoses
In LINH, diagnoses are coded using International Classi-
fication of Primary Care (ICPC-1); laboratory results are
unavailable within this registration system. In the major-
ity of cases, GPs make the definitive diagnosis of the epi-
sode based on microbiological diagnostics [6]. We
defined STI diagnoses as episodes registered with the
STI-specific codes for men and women shown in Table 1.
Episodes which the GP indicated with ICPC codes 'con-
cern or fear of STI or HIV/AIDS' were considered as STI-
related consultations.
Chlamydia has no specific code in ICPC-1 but is
recorded with codes for vaginitis (X84), cervicitis (X85)
or PID (X74) in women and orchitis/epididimytis (Y74)
or 'other genital diseases' (Y99) in men. Specific subcodes
for chlamydia diagnoses (X84.1, X85.1, X74.1, Y99.3);
exist within these main codes, but are not routinely used
(i.e. GPs often only register main codes). For our analyses,
we based the definition of chlamydia-diagnosis on a com-
b i n a t i o n  o f  c o d e  a n d  p r e s c r i p t i o n :  e p i s o d e s  w i t h  s u b -
codes were all counted as 'chlamydia', while episodes with
m a i n  c o d e s  w e r e  i n c l u d e d  o n l y  w h e n  l i n k e d  t o  c h l a -
mydia-related prescriptions Azythromycin, Doxycyclin,
Amoxicillin, Erythromycin, Ciprofloxacin and Ofloxacin
(coded by Anatomical Therapeutic Chemical Classifica-
tion System; see Table 1).
Data analyses
Trends in incidence rates in LINH were calculated using
multivariate multilevel repeated models for count data.
Poisson multilevel regression analyses were conducted
with three-level hierarchical structured data (patient,
general practice as cluster-variable and year of record-
ing), using MLWin 2.02 software. Not all practices could
be included because of differences in electronic registra-
tion systems (70-75% of practices per year). The number
of STI episodes was the outcome variable. The model was
adjusted for patients age- and gender and the practice's van den Broek et al. BMC Family Practice 2010, 11:39
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length of recording [14]. For HIV, syphilis, gonorrhea,
Trichomoniasis, NSU and 'fear of AIDS' counts were too
low and therefore adjusted models were made without
age/gender correction. Models were used to test linear
trends over time. Chlamydia prevalence estimates were
derived from the proportion of episodes with specified
ICPC diagnoses and medication, calculated with data
from 2006 and 2007. The total number of STI-related epi-
sodes at GPs was calculated by extrapolating to the Dutch
population.
STI centers
Data collection
The national STI surveillance based on data from STI
centers consists of records of consultations in a real-time
online database (SOAP), of clients' demographic charac-
teristics, STI history, sexual behavior, STI tests and diag-
nosis. This collective anonymous database is managed at
the RIVM for the purpose of national surveillance. Until
2002 this was based on voluntary registration of STI cen-
ters, which grew into a sentinel surveillance system of
main centers in 2003 (80% coverage). Since 2004, all exist-
ing STI centers (n = 32) are connected, hence providing
complete national coverage. The unit of reporting is 'cli-
ent-visit'; repeated consultations from one client cannot
be linked because of anonymousness.
Definition of STI diagnoses
In STI centers all STI diagnoses are laboratory-con-
firmed. Clients are routinely tested for chlamydia, gonor-
rhea and syphilis and the majority is also tested for HIV;
Hepatitis-B, Trichomoniasis and Herpes genitalis are
tested on indication; genital warts are reported option-
ally. Non-specific urethritis (NSU) is diagnosed based on
symptoms, leucocyturia and exclusion of other diagnoses
(Table 1).
Data analyses
STI reporting rates from SOAP were derived from real
counts of STI diagnoses seen at STI centers per year,
divided by the total Dutch population, based on the
assumption that the 32 centers have national coverage
although access to free testing is restricted to specific
groups. No correction was made for data from 2002-2003
when national coverage was not yet achieved, but roughly
estimated at about 80%. SPSS and SAS software was used
for analyses.
Results
From 2002 to 2007, 14,837 patient-episodes with ICPC
codes for STI or 'fear of STI/HIV' were registered in the
Table 1: Case-definitions of STIs
LINH (GP network)-ICPC* codes SOAP† (STI centers)
Men Women Men Women
STI-positive episodes
HIV infection/AIDS B90 HIV-test HIV-test
Non-specific urethritis U72 Not included Symptoms and exclusion of 
other STI
Not included
Syphilis Y70 X70 Syphilis test Syphilis test
Gonorrhea Y71 X71 Gonorrhea test Gonorrhea test
Trichomoniasis Not included X73 Not included Trichomonas test
Herpes genitalis Y72 X90 Symptoms, confirmed by test Symptoms, confirmed by test
Genital warts Y76 X91 Symptoms Symptoms
Chlamydia
- main codes‡ Y74, Y99 X84, X85, X74 Chlamydia test Chlamydia test
- sub codes Y99.3 X84.1, X85.1, 
X74.1
STI-related episodes
Fear of HV/AIDS
B25 B25 All consultations without one of the above STI-diagnoses
Fear of STI Y25 X23
* ICPC = International Classification of Primary Care
† SOAP = National Surveillance of STI centers
‡ Chlamydia defined by main codes combined with prescriptions of antibiotics with following ATC-codes: J01FA10 J01AA02 J01CA04, 
J01CR02 J01FA01 J01MA01 or J01MA02 van den Broek et al. BMC Family Practice 2010, 11:39
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LINH GP surveillance network, which amounted to 0.4%
of all episodes recorded, about 40 per practice per year
(23 per fulltime-equivalent). At STI centers 352,524 cli-
ent-visits were recorded, ranging from 200 per year in
small (sub)centers to 26,000 in the largest clinic in
Amsterdam.
STI-trends
There was a steady rise in demand for STI care over the
period 2002-2007. At GPs, the incidence of STI-related
episodes (STI + fear of STI/HIV) increased by 44%, from
664 per 100,000 patients in 2002 to 955/100,000 in 2007,
equivalent to about 110,000 to 160,000 episodes country-
wide. In this same period the number of client-visits at
STI centers increased by 86% from 42,000 to 78,000 (263
to 488 per 100,000 inhabitants), more than expected due
to 20% expansion of the centers under surveillance. The
incidence of STI-positive cases (diagnosed with HIV,
chlamydia, gonorrhea, syphilis, genital warts, Herpes gen-
italis, NSU or Trichomoniasis) increased by 20% at GPs
and by 30% at STI centers from 2002 to 2007. At both
facilities, the number of patients with STI-related nega-
tive episodes doubled (see Figure 1).
The ratio between STI-related episodes at GPs and STI
centers decreased from 2.6:1 in 2002 to 2.0:1 in 2007. In
2007, two third of STI-related episodes was seen by GPs
and one third by STI centers. Of all STI-positive episodes,
83% was recorded at GPs and 17% at STI-centers (81% of
male and 85% of female STI-cases at GPs).
Population differences
Visitors at STI centers were on average younger (30 years
± 0.04 SEM) than STI-patients at GPs (32 years ± 0.22
SEM, data 2007). The proportion of people under 25
years at STI centers was 40% and at GPs 35%; for women
this was 54% versus 41%; 50-plussers represented 9% of
STI patients at GPs and 5% at STI centers. The propor-
tion of male clients was higher at STI centers than at GPs:
51% of visitors at STI centers were male and 44% of GP-
patients with STI-related episodes were male.
About one third (38%) of the LINH-patient-population
lived in highly urbanized areas; 9.5% lived in deprived
areas. Patients with STI-related problems were more fre-
quently from highly urbanized areas (62%); 17.6% lived in
deprived areas. The client-population at STI centers
could not be characterized in this way, but is assumed to
be predominantly urban, because most STI centers are
located in cities and the majority is seen at centers in the
four largest Dutch cities (Amsterdam, Rotterdam, The
Hague, Utrecht). At STI centers, specific high-risk groups
were men who have sex with men (MSM, 28% visitors in
2007), female sex workers (9% of women) and clients of
sex workers (9% of men).
Chlamydia episodes at GPs
In a separate questionnaire to GPs participating in LINH
(in 2007), the majority of GPs indicated to use sub codes
for chlamydia. In 2006 and 2007, 454 episodes with chla-
mydia-specific ICPC sub codes were recorded. In addi-
tion, out of 4990 episodes with chlamydia-related main
codes, 601 could be linked to chlamydia-prescriptions.
This resulted in 1055 episodes of chlamydia by our case-
definition. Five hundred sixty four episodes (53%) were in
women, of which 26% was recorded with ICPC code X74
(PID), 47% with X84 (vaginitis) and 27% with X85 (cervi-
citis). In men, 41% of chlamydia episodes were recorded
under Y74 (orchitis/epididimytis) and 59% under Y99
(other genital disease including chlamydia subcode). The
proportion of chlamydia per ICPC code was 57% of X74
(PID), 8% of X84 (vaginitis), 51% of X85 (cervicitis), 32%
of Y74 (orchitis/epididymitis) and 39% of Y99 (other gen-
ital diseases men).
Based on these results, the estimated reporting rate of
chlamydia in 2006 and 2007 was 174 per 100.000. Chla-
mydia episodes were equally diagnosed in women (186/
100,000) and in men (162/100,000). Of chlamydia
patients under 25 years 83% were female. Male chlamydia
patients were over-represented in the group of 50 years
and older (81%).
Trends in STI-diagnoses 2002-2007
The most common STI at GPs was chlamydia, followed
by genital warts and Herpes genitalis (Figures 2A and 3A).
There was a significant linear increase in case-reports of
chlamydia (in men and women) as well as genital warts
and Herpes genitalis (in women), whereas rates of other
STI infections remained relatively stable. Reporting rates
for syphilis, gonorrhea and HIV at GPs were lower than
the other STI; for syphilis no GP data were available for
2002-2004.
Figure 1 Annual number of STI episodes at GPs (divided in STI-re-
lated episodes, i.e. fear of STI/HIV, and episodes with STI/HIV diagno-
ses) and consultations at STI centers, divided in negative 
consultations (without diagnosis) and positive STI/HIV diagnoses, 
LINH-DB and SOAP surveillance, the Netherlands, 2002-2007.
Annual number of STI-related episodes at GPs and STI centers van den Broek et al. BMC Family Practice 2010, 11:39
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Chlamydia was also the most commonly reported STI
at STI centers (Figures 2B and 3B) and its reporting rate
rose sharply, in par with the rise in number of visitors to
STI centers. Other STIs had quite stable reporting rates.
Chlamydia, gonorrhea and syphilis were relatively more
frequent diagnoses at STI centers, whereas Trichomonia-
sis, urethritis, Herpes genitalis and genital warts were
more frequently recorded in general practices. HIV inci-
dence was relatively high at GPs when compared to the
STI centers. Chlamydia was reported at similar rates in
men and women, both at GPs and at STI centers. Genital
warts and Herpes genitalis were more often recorded in
women but gonorrhea, syphilis and HIV more in men
(Figure 3).
Figure 2 Trends in STI-diagnoses registered by GPs (A) and STI centers (B) in the Netherlands, 2002-2007. Estimates from GP surveillance 
(LINH-DB) extrapolated of 60 sentinel surgeries and numbers from national surveillance of 32 STI centers (SOAP).
Trends in STI-diagnoses at GPs and STI centers van den Broek et al. BMC Family Practice 2010, 11:39
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Discussion
The STI healthcare seeking behavior in the Netherlands
has increased considerably in recent years, both at GPs
and STI centers. The rise was mainly due to a growing
demand for testing and concern for STIs and to a lesser
extent to increased STI-diagnoses. The total estimate at
STI centers and at GPs equaled to an incidence of 1443
STI-related episodes and 570 STI-diagnoses per 100,000
persons in 2007. The increase in the sexual health seeking
behavior is encouraging: rising from 0.9 to 1.4 consulta-
tions per 100 persons per year and even 4.3 per 100
young people under 25 years in 2008. This resulted in
more STI diagnosis in recent years, especially of Chla-
mydia. About 70% of STI-related episodes were seen by
GPs and 30% at STI centers; GPs accounted for 80-85% of
positive STI-diagnoses. The incidence of chlamydia diag-
noses increased strongly in STI centers and, to a lesser
extent, at GPs. This reflects to a large extent the increase
in testing volume; the positivity rate at the STI centers
changed only moderately (from 9.2% in 2001 to 10.8% in
2008) [5]. Chlamydia case-reports in the two facilities
together amounted to an estimated 36,000 cases per year
in the Netherlands. STI centers saw relatively more young
people and more male clients than GPs. Patients at STI
centers were more at risk for STIs such as gonorrhea and
syphilis, whereas GPs received more patients with genital
warts,  Herpes genitalis, urethritis and Trichomoniasis.
STI centers fulfilled part of the growing demand for STI
care, but did not 'take over' from GPs, who clearly remain
the major firstline providers of STI care in the Nether-
lands. Both facilities saw rising numbers, indicating
improved access to STI testing and -care and/or better
awareness in the population.
Limitations
Our analysis has several limitations due to the nature of
the data sources.
Unfortunately laboratory results were not retrievable
from the GPs EMR database, which makes unequal com-
parison to diagnoses in STI-centers. GPs nevertheless use
laboratory tests to determine the final diagnosis of STI
episodes in accordance with Dutch Guidelines for Pri-
mary Care, but we could not exclude misclassification.
We recommend laboratory results to be included within
future data extracts.
A second constraint was the absence of a specific ICPC
code for chlamydia at GPs. Chlamydia can be reported
with a sub-code in the ICPC classification, but most GPs
register only main codes. Therefore we included chla-
mydia medication in our search strategy. This search
strategy might induce a certain degree of overestimation.
We found relatively high incidences in elderly men, where
most genital infections are probably not STI related. Fur-
thermore, chlamydia cases in women included diagnoses
with codes for PID and also vaginitis, which is normally
not caused by chlamydia, but controversially, a subcode
'vaginitis by chlamydia' exists in ICPC. Chlamydia, as the
most prevalent STI, should have its own ICPC code.
For low-incident infections like syphilis and HIV, better
recording at GPs is needed. In contrast to chlamydia and
gonorrhea infections these patients are often referred to
secondary level. Due to recording of cases as 'new HIV
infection' at the GP which may already have been
reported elsewhere, substantial double counting may
arise. The annual number of HIV-infections based on
data presented here would be about 2500 in recent years,
whereas current figures of HIV-monitoring show only
around 1000 new cases per year are admitted to HIV-
treatment centers [5]. More information on the registra-
tion of HIV-infections at GPs is desirable, because of
uncertainties about the -presumably substantial- number
of HIV-positives unaware of their status [21].
Discussion of findings
Differences in population characteristics of patients at
GPs and STI centers suggest that each facility serves a dif-
ferent target-group. Clients at STI centers seem to come
more often for a preventive STI-check-up (without obvi-
ous symptoms) and GP patients with commonly symp-
tomatic STIs. The threshold to go for an (anonymous)
STI-check is low at STI centers offering free testing to
high-risk groups. The proportion of MSM at STI centers
Figure 3 Incidence of STIs in male and female patients seen at 
GPs (LINH-DB 2006) and at STI centers (SOAP 2007). Bars indicate 
95% confidence intervals.
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(28% of men) was much higher than 3-8% estimated in
the general population [7] and among GP patients [22].
GP patients are probably less often from high-risk groups
[23] than in STI centers, however we saw that a substan-
tial group came from highly urbanized or deprived areas.
To determine to what extent specific STI risk-groups also
come to GPs, more background information, such as sex-
ual preference or reason for consultation, is needed.
Compared to other countries, GPs in the Netherlands
play a large role in STI care. In Belgium, the major part of
STIs is also detected by GPs, since most of the population
at risk has access to this setting only for STI care [24]. In
Germany, data from sentinel surveillance suggest that
private practitioners see smaller numbers of STI-patients
than hospital-based STI clinics or local health offices;
their patients are less often from high-risk groups [10]. In
the UK, the majority of STI diagnoses are made at Geni-
tourinary Medicine (GUM) clinics, though a substantial
proportion of chlamydia cases in females is diagnosed at
GPs [11,12]. In the US STI care is spread over different
facilities [25]. In Australia, a cross sectional survey
among GPs showed that GPs are confronted with STI-
related problems regularly, although the STI diagnosis
often remained unconfirmed [26,27].
The incidence of STI-related episodes we found (1400/
100,000) is quite similar to reports of 1.2% of adults with
self-reported signs and symptoms suggestive of an STI
[7], but lower than the reported 4% of adults who had an
STI/HIV check-up [8]. The ratio of consultations at GPs
versus STI centers is in line with earlier data [5,7,8,28].
The 36,000 chlamydia cases we estimated per year is
lower than the 60,000 per year estimated in a chlamydia
pilot screening [29], but the difference can be explained
by the proportion asymptomatics, which only come for-
ward in a screening program.
A comparison with other European countries shows
that the incidence rates we estimated for chlamydia (220/
100,000, from GP + STI centers together), gonorrhea (39/
100,000) and syphilis (11/100,000) are higher than overall
averages for Europe reported by ECDC: chlamydia 92/
100,000, gonorrhea 9/100,000 and syphilis 4/100,000 [30].
This may be due to actual differences in incidence, or the
relatively easy access to STI-care in the Netherlands and
related testing-rates, but also to completeness of report-
ing. Current STI surveillance systems across Europe show
a large heterogeneity [10,31]. Data are more complete in
northern European countries, where they are based on
comprehensive case reports from diverse medical care
facilities (Scandinavian countries) or main STI-care pro-
viders (GUM clinics, UK) [32]. Our incidence rates for
chlamydia and gonorrhea are in line with rates reported
from these northern European countries to ESSTI [32],
but our syphilis rates were higher than theirs. The inci-
dence rates in the United States, where these three STIs
are notifiable diseases, are higher for chlamydia (370/
100.000) than in the Netherlands but comparable to some
other northern European countries; gonorrhea incidence
is also higher in the US while syphilis rates in the US are
similar to European levels [25]. Incidence rates for chla-
mydia in the Netherlands were similar in men and
women, whereas in most other northern European coun-
tries incidence rates in women are higher [32]. In the UK
the male:female ratio is balanced as well [32]. In the US
chlamydia incidence is three times higher in women [25].
Differences may be explained by access to care and STI-
testing habits.
Conclusion
In conclusion, the addition of data from GP surveillance
will improve the completeness of surveillance of the main
STIs in the Netherlands and facilitate international com-
parisons. For low-prevalent STIs such as syphilis and
HIV, data from the GP network may be limited. GPs still
attend to the majority of STI patients in the Netherlands
even though the popularity of publicly funded STI cen-
ters increased.
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